Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Kalorama Reports | Minimally Invasive Surgical Devices, World Market

Minimally Invasive Surgical Devices, World Market

Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation.

The report includes product information, procedure volume data, world demographics; and other general issues affecting the MIS device market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers.

Additionally key company profiles are included. Revenues for each segment were gathered through both primary and secondary research methods. Additionally, the report provides detailed information regarding procedure volumes for six general areas of surgery, including:

* Orthopedic Devices

* Neurosurgery Devices

* ENT/Respiratory Devices

* Cardiovascular Devices

* Gastrointestinal System Devices

* Urological and Gynecological Devices

In this report total revenues for all minimally invasive equipment sales in each of the categories above are provided. Five year forecasts are also provided.

As this is a global survey, Revenues are provided for the following regions:

* US

* Europe

* Rest of World

Procedure volumes are available for the following surgeries for which minimally invasive equipment is utilized:

* Hip Replacement, Pinning, etc.

* Knee Repair/Fixation, Procedures

* Spinal Fusion/Spinal Hardware Removal

* Shoulder Repair/Fixation

* Lumbar Laminectomy/ Thoracic-lumbar

* Laminectomy/Diskectomy and Lumbar Decompression and Fusion

* Craniotomy (all types)

* Ventricular-Peritoneal Shunt Insertion/ Removal/Revision

* Detether Cord (adult and pediatric)

* Ethmoidectomy

* Tonsillectomy

* Thyroidectomy

* Coronary Revascularization

* Aortic Valve Replacement or Repair

* Cardiac Catheterization

* Insertion of Coronary Artery Stent(s)

* Appendectomy

* Endoscopy with or without biopsy

* Cholecystectomy

* Inguinal Herniorrhaphy

* Hysterectomy (all types)

* Prostatectomy

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 45 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives:

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. Competitive analysis is provided for the year 2007. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Countries covered: Global September 1, 2008 250 Pages
Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions